MGNX
Macrogenics Inc

4,048
Mkt Cap
$86.66M
Volume
5.12M
52W High
$3.64
52W Low
$0.9896
PE Ratio
-1.14
MGNX Fundamentals
Price
$1.37
Prev Close
$1.38
Open
$1.39
50D MA
$1.61
Beta
1.52
Avg. Volume
857,268.16
EPS (Annual)
-$1.07
P/B
1.29
Rev/Employee
$439,771.26
Loading...
Loading...
News
all
press releases
MacroGenics, Inc. (NASDAQ:MGNX) Receives Consensus Rating of "Moderate Buy" from Brokerages
MacroGenics, Inc. (NASDAQ:MGNX - Get Free Report) has received an average rating of "Moderate Buy" from the seven brokerages that are presently covering the company, MarketBeat.com reports. One...
MarketBeat·9d ago
News Placeholder
More News
News Placeholder
Leerink Partnrs Increases Earnings Estimates for MacroGenics
MacroGenics, Inc. (NASDAQ:MGNX - Free Report) - Investment analysts at Leerink Partnrs increased their FY2025 earnings per share (EPS) estimates for shares of MacroGenics in a report issued on...
MarketBeat·19d ago
News Placeholder
MacroGenics (NASDAQ:MGNX) Stock Rating Upgraded by Zacks Research
Zacks Research upgraded shares of MacroGenics from a "hold" rating to a "strong-buy" rating in a report on Thursday...
MarketBeat·20d ago
News Placeholder
MacroGenics (NASDAQ:MGNX) Issues Earnings Results, Beats Estimates By $0.75 EPS
MacroGenics (NASDAQ:MGNX - Get Free Report) released its quarterly earnings results on Wednesday. The biopharmaceutical company reported $0.27 earnings per share (EPS) for the quarter, topping the...
MarketBeat·23d ago
News Placeholder
MacroGenics (MGNX) Q3 Earnings and Revenues Surpass Estimates
MacroGenics (MGNX) delivered earnings and revenue surprises of +156.25% and +157.20%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·24d ago
News Placeholder
MacroGenics (MGNX) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
After losing some value lately, a hammer chart pattern has been formed for MacroGenics (MGNX), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
Zacks·26d ago
News Placeholder
Stryker (SYK) Q3 Earnings and Revenues Beat Estimates
Stryker (SYK) delivered earnings and revenue surprises of +1.59% and +0.24%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
MacroGenics (MGNX) Reports Q2 Loss, Tops Revenue Estimates
MacroGenics (MGNX) delivered earnings and revenue surprises of +3.39% and +4.73%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·4mo ago
News Placeholder
OrganiGram (OGI) Reports Q3 Loss, Beats Revenue Estimates
OrganiGram (OGI) delivered earnings and revenue surprises of -200.00% and +5.86%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·4mo ago
News Placeholder
SNDL Inc. (SNDL) Surpasses Q2 Earnings and Revenue Estimates
SNDL INC (SNDL) delivered earnings and revenue surprises of +125.00% and +6.13%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·4mo ago

Latest MGNX News

View

Advertisement|Remove ads.

Advertisement|Remove ads.